Plasma MIP-1beta levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib (Q46695473)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma MIP-1beta levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib |
scientific article |
Statements
1 reference
Plasma MIP-1beta levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib (English)
1 reference
Hideharu Kimura
1 reference
Kazuo Kasahara
1 reference
Masaru Sekijima
1 reference
Tomohide Tamura
1 reference
Kazuto Nishio
1 reference
8 September 2005
1 reference
1 reference
50
1 reference
3
1 reference
393-399
1 reference